Skip to main content
. 2018 Jul 11;218(8):1191–1199. doi: 10.1093/infdis/jiy306

Table 4.

Torque Teno Virus Levels Stratified According to Baseline Characteristics

Characteristics TTV Copies/mL (IQR) P Value
Variable Positivea Variable Negativea
Recipient data
 Recipient age >56 yearsb 4.2 × 108 (1.8 × 107–2.9 × 109) 3.2 × 107 (3.6 × 106–4.0 × 108) .050
 Recipient female 9.3 × 106 (1.8 × 106–3.4 × 108) 3.4 × 108 (1.8 × 107–2.4 × 109) .021
 Recipient BMI >26 kg/m2 b 4.2 × 108 (3.4 × 106–1.7 × 109) 6.8 × 107 (8.3 × 106–4.2 × 108) .629
 Renal replacement therapy >2.6 yearsb, c 5.2 × 107 (5.3 × 106–8.3 × 108) 1.8 × 108 (3.3 × 106–2.7 × 109) .589
 Diabetes mellitus 1.7 × 107 (2.8 × 106–4.3 × 108) 1.8 × 108 (5.0 × 106–1.5 × 109) .243
 Major comorbidityd 5.2 × 107 (4.0 × 106–1.5 × 109) 1.4 × 108 (3.9 × 106–1.1 × 109) .978
 CMV IgG positive 2.9 × 107 (3.4 × 106–5.3 × 109) 4.3 × 108 (1.8 × 108–2.9 × 109) .003
 EBV IgG positive 7.6 × 107 (4.1 × 106–1.4 × 109) 3.8 × 108 (3.5 × 108–NA) .415
 HBc antibody positive 7.3 × 106 (3.6 × 106–1.4 × 108) 2.6 × 108 (8.0 × 106–1.7 × 109) .074
 HIV antibody/antigen positive NA NA .366
Donor data
 Living donor 9.9 × 107 (1.2 × 107–4.3 × 108) 1.8 × 108 (4.1 × 106–1.4 × 109) .884
 Donor after circulatory death 1.7 × 108 (1.6 × 105–7.6 × 108) 2.4 × 108 (7.3 × 106–1.8 × 109) .203
 Donor age >56 yearsb 4.2 × 108 (9.3 × 106–2.9 × 109) 3.0 × 107 (3.8 × 106–4.2 × 108) .014
 Donor female 3.1 × 107 (3.9 × 106–1.6 × 109) 2.2 × 108 (7.2 × 106–1.0 × 109) .699
 Donor CMV IgG positive 3.4 × 107 (3.8 × 106–2.1 × 109) 4.2 × 108 (1.1 × 107–1.6 × 109) .164
Transplant data
 Retransplantation 1.0 × 107 (9.9 × 105–3.3 × 108) 2.6 × 108 (9.3 × 106–1.7 × 109) .041
 ABO incompatible transplantation 1.0 × 106 (6.3 × 105–1.8 × 109) 1.8 × 108 (7.3 × 106–1.3 × 109) .633
 Donor specific antibody 2.5 × 107 (1.8 × 106–2.1 × 108) 1.8 × 108 (5.3 × 106–1.4 × 109) .238
 HLA A, B, DR mismatch >3b 4.7 × 107 (2.8 × 106–1.3 × 109) 1.8 × 108 (7.3 × 106–1.3 × 109) .486
 ATG induction 1.9 × 107 (2.3 × 106–1.5 × 108) 1.8 × 108 (5.2 × 106–1.5 × 109) .193
 CMV prophylaxis 4.0 × 108 (4.0 × 107–1.8 × 109) 3.1 × 107 (3.7 × 106–1.2 × 109) .067

Mann-Whitney U test was used for comparing continuous data and group comparisons were made using the Χ2 test. Exact tests were used where applicable.

Abbreviations: ATG, antithymoglobulin; BMI, body mass index; CMV, cytomegalovirus; EBV, Epstein Barr virus; HBc, hepatitis B-core antigen; HIV, human immunodeficiency virus; HLA, human leukocyte antigen; IgG immunoglobulin G; IQR, inter quartile range; NA, not applicable; TTV, torque teno virus.

aTTV levels preceding the first documented event (infection or no infection) per patient were analyzed.

bCutoff defined by median.

cTime between the start of renal replacement therapy and transplantation.

dAny history of major cardiovascular, gastrointestinal, pulmonary, or malignant disease.